University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Ryutaro Hirose, MD

Ryutaro Hirose, MD

Assistant Professor, Department of Surgery, UCSF

Selected Publications

  1. Bertsimas D, Papalexopoulos T, Trichakis N, Wang Y, Hirose R, Vagefi PA. Balancing efficiency and fairness in liver transplant access: tradeoff curves for the assessment of organ distribution policies. Transplantation. 2019 Oct 21.
    View on PubMed
  2. Roll GR, Webber AB, Gae DH, Laszik Z, Tavakol M, Mayen L, Cunniffe K, Syed S, Hirose R, Freise C, Feng S, Roberts JP, Ascher NL, Stock PG, Rajalingam R. A virtual crossmatch based strategy facilitates sharing of deceased donor kidneys for highly sensitized recipients. Transplantation. 2019 Aug 19.
    View on PubMed
  3. Parekh JR, Hirose R, Foley DP, Grieco A, Cohen ME, Hall BL, Ko CY, Greenstein S. Beyond death and graft survival-Variation in outcomes after kidney transplantation. Results from the NSQIP Transplant beta phase. Am J Transplant. 2019 Sep; 19(9):2622-2630.
    View on PubMed
  4. Cullaro G, Hirose R, Lai JC. Changes in Simultaneous Liver-kidney Transplant Allocation Policy May Impact Postliver Transplant Outcomes. Transplantation. 2019 May; 103(5):959-964.
    View on PubMed
  5. Parekh JR, Greenstein S, Sudan DL, Grieco A, Cohen ME, Hall BL, Ko CY, Hirose R. Beyond death and graft survival-Variation in outcomes after liver transplant. Results from the NSQIP transplant beta phase. Am J Transplant. 2019 Jul; 19(7):2108-2115.
    View on PubMed
  6. Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY. Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation. Am J Transplant. 2019 Aug; 19(8):2210-2218.
    View on PubMed
  7. Hirose R. State-Based Liver Allocation: Is It a Viable Alternative? Liver Transpl. 2019 Apr; 25(4):535-537.
    View on PubMed
  8. Gao Y, Twigg AR, Hirose R, Roll GR, Nowacki AS, Maytin EV, Vidimos AT, Rajalingam R, Arron ST. Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant. JAMA Dermatol. 2019 Mar 01; 155(3):307-314.
    View on PubMed
  9. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes. Hepatology. 2019 Mar; 69(3):1193-1205.
    View on PubMed
  10. Bertsimas D, Kung J, Trichakis N, Wang Y, Hirose R, Vagefi PA. Development and validation of an optimized prediction of mortality for candidates awaiting liver transplantation. Am J Transplant. 2019 Apr; 19(4):1109-1118.
    View on PubMed
  11. Cooper M, Formica R, Friedewald J, Hirose R, O'Connor K, Mohan S, Schold J, Axelrod D, Pastan S. Report of National Kidney Foundation Consensus Conference to Decrease Kidney Discards. Clin Transplant. 2019 01; 33(1):e13419.
    View on PubMed
  12. Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY. Increasing Liver Transplantation Wait-List Dropout for Hepatocellular Carcinoma With Widening Geographical Disparities: Implications for Organ Allocation. Liver Transpl. 2018 10; 24(10):1346-1356.
    View on PubMed
  13. Patel MS, Hirose R, Vagefi PA. How Good Is Good? Benchmarking and the Quest for Quality Improvement in Liver Transplantation. Ann Surg. 2018 03; 267(3):426-427.
    View on PubMed
  14. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form. Clin Transplant. 2017 Nov; 31(11).
    View on PubMed
  15. Hirose R, Heimbach J. Defining disparities in liver transplantation: The devil is in the details. Liver Transpl. 2017 04; 23(4):557-558.
    View on PubMed
  16. Deshpande R, Hirose R, Mulligan D. Liver allocation and distribution: time for a change. Curr Opin Organ Transplant. 2017 Apr; 22(2):162-168.
    View on PubMed
  17. Hart A, Schladt DP, Zeglin J, Pyke J, Kim WR, Lake JR, Roberts JP, Hirose R, Mulligan DC, Kasiske BL, Snyder JJ, Israni AK. Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points. Transplantation. 2016 10; 100(10):2153-9.
    View on PubMed
  18. Gentry SE, Hirose R, Mulligan D. Resolving Misconceptions About Liver Allocation and Redistricting Methodology. JAMA Surg. 2016 10 01; 151(10):991-992.
    View on PubMed
  19. Parekh J, Roll GR, Wisel S, Rushakoff RJ, Hirose R. Effect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clin Transplant. 2016 10; 30(10):1242-1249.
    View on PubMed
  20. Kim SS, Nakakura EK, Wang ZJ, Kim GE, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Ko AH. Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy? J Surg Oncol. 2016 Oct; 114(5):587-596.
    View on PubMed

Go to UCSF Profiles, powered by CTSI